|
HS Code |
564519 |
| Cas Number | 73-05-2 |
| Molecular Formula | C15H24N2O |
| Molar Mass | 248.36 g/mol |
| Iupac Name | 2',6'-Pipecoloxylidide |
| Synonyms | Lidocaine base |
| Appearance | White crystalline solid |
| Melting Point | 66-69°C |
| Boiling Point | 350°C at 760 mmHg |
| Solubility In Water | Slightly soluble |
| Density | 1.03 g/cm³ |
| Logp | 2.26 |
| Pka | 7.9 |
As an accredited 2',6'-Pipecoloxylidide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White high-density polyethylene (HDPE) bottle, screw cap, tamper seal, labeled, containing 25 grams of 2',6'-Pipecoloxylidide, with hazard warnings. |
| Shipping | 2',6'-Pipecoloxylidide is shipped in tightly sealed, chemical-resistant containers to prevent leaks and contamination. It is transported under cool, dry conditions, in compliance with relevant regulations regarding hazardous materials. Ensure proper labeling and documentation, and handle with appropriate personal protective equipment to avoid exposure during transit. |
| Storage | 2',6'-Pipecoloxylidide should be stored in a tightly sealed container, away from moisture, light, and incompatible substances such as oxidizing agents. Store at room temperature in a cool, dry, well-ventilated area, and avoid excessive heat. Proper labeling and secure shelving are essential to prevent accidental exposure or spillage. Follow all applicable chemical storage regulations and safety guidelines. |
Applications of 2',6'-Pipecoloxylidide in Industrial Manufacturing2',6'-Pipecoloxylidide serves as a specialized intermediate in several regulated chemical industries, particularly in the synthesis of pharmaceuticals and active pharmaceutical ingredients. Its use depends on strict adherence to process standards, formulation accuracy, and downstream integration requirements set by industry authorities. Our production supports high-purity demand and enables direct compliance with international specifications for each downstream sector. 1. Pharmaceutical Active Ingredient Synthesis – Local Anesthetics ProductionPharmaceutical manufacturers employ 2',6'-Pipecoloxylidide as a precursor for the synthesis of amide-type local anesthetics, particularly in the production of ropivacaine and related compounds. It enters the route after initial ring construction, where it undergoes amide formation under controlled temperature and pH conditions to preserve its stereochemistry. Production adheres to fine-tuned stoichiometry that maximizes yield and purity; the precise ratio of raw material depends on the selected synthetic pathway, solvent, and catalyst system. Downstream, manufacturers integrate the intermediate at the crude condensation or amidation stage, controlling the batch record for full traceability. Final APIs are submitted to comprehensive chemical, chromatographic, and impurity profiling, supporting injectable, topical, or infiltrative anesthetic finished forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Custom Synthesis for Veterinary DrugsAnimal health formulation companies use 2',6'-Pipecoloxylidide to synthesize amide-linked anesthetic agents for veterinary applications. The material enters the process at the amide linkage formation stage, where precise process controls maintain stereoisomeric purity necessary for veterinary compliance. Formulators adjust the ratio depending on targeted species, route of administration, and batch size. Quality teams validate the intermediate against global veterinary pharmacopoeia, including required impurity profiles and residual solvent levels. Manufacturers integrate the intermediate directly into the stepwise synthesis of injectable or topical local anesthetics, ensuring raw material chain traceability and batch-level purity documentation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Contract API Manufacturing – Clinical Research Batch ProductionGlobal contract development and manufacturing organizations (CDMOs) utilize 2',6'-Pipecoloxylidide as a critical intermediate in phased clinical trial synthesis protocols. Process chemists introduce the material in test-scale or pilot-scale batch records at the stage where time-sensitive coupling reactions demand consistent reactivity and traceable source data. The feedstock ratio depends on precise route design, target yield, and impurity target specifications as specified in the batch synthesis protocol. cGMP controls ensure that intermediate production aligns with documentation expectations for Phase I through Phase III trials and submission to authorities such as FDA or EMA. The intermediate is batch-controlled, with all quality documentation retained for investigational drug submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis of Research-Grade Reference StandardsCertified reference material laboratories and analytical chemical suppliers apply 2',6'-Pipecoloxylidide as a core building block in the synthesis and certification of metabolite and impurity reference standards. The compound’s batch-to-batch consistency and high assay purity support reproducible synthesis routes, facilitating high-precision chemical derivatization and isolation. Users carefully balance the usage ratio to maximize standard yield while minimizing by-products, adjusting protocol parameters based on required purity for ISO 17034 and ISO Guide 34 certification. Isolation and characterization typically follow direct on-line HPLC purification and full NMR/MS verification before certification as reference material. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2',6'-Pipecoloxylidide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
We have worked closely with 2',6'-Pipecoloxylidide for over a decade in our plant, refining each step from raw material procurement to purification. To many, this compound represents just another intermediate, but behind its synthesis lies a story of constant troubleshooting, optimization, and attention to consistency. Our drive to make this compound goes back to our roots in pharmaceutical production, where understanding both the fine chemistry and the downstream impact on processes like local anesthetic synthesis always remained central to us.
On the production line, details start with choosing the right 2,6-xylidine and pipecolic acid inputs, both of which influence the reaction’s cleanliness. Early on, we struggled with small variations in batch color and yield, discovering that temperature control during amide coupling changed the impurity profile. Our process engineers invested months in adjusting reactor volumes and solvent drying steps, using gas chromatography to verify each improvement. Staff here joke that no one can walk past the reactors for this stage without giving a quick sniff test—it signals whether the synthesis ran smooth or picked up by-product notes, something only years of batch records can teach.
2',6'-Pipecoloxylidide forms a backbone for popular local anesthetics, including ropivacaine and bupivacaine. Hospitals and pharmaceutical companies rely on precisely-manufactured intermediate grades to get reproducible yields during their final drug synthesis. A single error upstream can cost days of troubleshooting downstream. Not many outsiders realize that even a percentage point shift in purity leads to off-spec color in injectable solutions—something regulatory authorities and practitioners notice immediately.
We observe this impact from our side of the industry. Sometimes, customers report back about purification headaches or stability problems, and through these conversations, we've shaped our purification steps. For example, strict isolation of the product at the right pH and temperature gives a crystalline solid that filters easily, without sticky residues. Chemists on site have learned over the years which filtration rates tie back to future solubility problems.
Our primary production line generates 2',6'-Pipecoloxylidide in commercial lots, typically ranging from 50 kg pilot trials up to multi-ton annual production runs. We keep each lot’s measured melting range, density, and assay results tied directly to the line that produced it so quality tracking has no guesswork. On paper, what matters most is an HPLC purity above 99.5%, with precise moisture limits. What matters in daily work, however, is being able to hit that target lot after lot without excess cost or rework, helping formulators skip repeated re-validations.
We handle packaging in dual-lined fiber drums or fluoropolymer containers, depending on the next process step at the customer's plant. For any special requirements—like higher-pressure ampoule filling or tighter particle size distribution—we talk directly with customer chemists to avoid surprises. Temperature logging and container tracking are not formalities here; each detail feeds into our traceability and future improvements.
In research batches, we supply flexible pack sizes for universities or startup pharmaceutical companies. These customers need quick results, easy solubilization, and a product that doesn’t add variables to their test reactions. Lab managers regularly call us with questions about solubility or handling. Over time, our technical staff has compiled a set of best practices: store 2',6'-Pipecoloxylidide in a moisture-tight vessel, avoid repeated heating-cooling cycles, and check for any off-odor indicating solvent residues.
Once scales move to industrial production, demands shift. Line operators ask about dusting, flow properties, and batch-to-batch blending. At full scale, the same chemistry runs for hours or days, so we design particle sizing to prevent clumping and to feed into reactors seamlessly. Our staff have even trained customer teams on real plant floors, sharing what we've learned about minimizing downtime and avoiding material wastage. That level of interaction cannot be copied from a vendor who only trades on paper.
Large buyers notice quality, but we believe long-term trust builds through transparency and responsiveness. After every run, we analyze not just purity, but also trace residues of metals and organic solvents. Our batch control teams track how minute changes in solvent ratio or agitation speed affect the downstream chemistry. This lets us talk plainly about risk factors if a customer ever hits a snag.
We work with pharmaceutical auditors and consultants to challenge our own QC program, inviting on-site reviews and sharing our full process documentation. During regulatory inspections, we demonstrate exactly how each finished lot tracks back to individual raw material lots, using a hybrid paper and electronic record system that gives both rugged dependability and instant reference access. One reason clients trust us is our willingness to walk them through failures and learnings, not just celebrate passing results.
The market holds several different grades, but many of the differences hinge on subtleties most traders overlook. Some sell under-dried material, packaged just to move volume. Others skip advanced analytics to “meet spec” by the numbers but ignore secondary impurities. Over the years, we’ve helped several customers unwind supply chain failures—typically after a cheaper batch forced full process re-validation or troubleshooting in their own line.
We don’t compete on price by cutting quality. Instead, we put in the extra filtration and spectral checks to make sure unknown by-products don’t slip through. As a manufacturer, we see exactly how temperature, mixing speed, and holding time trace through final performance. We train staff to log each anomaly, from crust formation on reactor walls to changes in product dryness, and use those lessons to drive process improvement. In tough markets, this close attention to the manufacturing experience is what keeps long-term clients and avoids costly surprises.
Producing 2',6'-Pipecoloxylidide puts us right in the middle of a chain running from fine chemical synthesis shops upstream, to hospitals, wholesalers, and patients downstream. Quality issues or poor communication echo through every link. We know that any error in our step means not just lost time, but real impacts for patients awaiting anesthesia in surgery rooms. That sense of responsibility shapes not only how we work but also how we talk with our customers.
We source only from vetted upstream suppliers, complete full lot traceability tracking, and adhere to in-house protocols well beyond minimum regulatory expectations. Regular training with our staff focuses on recognizing and correcting issues, as we do not believe in passing along problems hoping the next user will solve them.
On factory floors, safety is not paperwork—it's the shield that lets our people work confidently batch after batch. Our teams work with gloves, goggles, and exhaust ventilation, but we also design each process line to contain odors and prevent dust exposure. Managers and team members share responsibility for flagging any unsafe practice. We regularly rotate staff through different stages to prevent fatigue-driven oversight.
We store and move 2',6'-Pipecoloxylidide in sealed, inert-lined containers, only opening batches under controlled conditions. To prevent any issues from product degradation, we monitor storage area temperature and humidity around the clock using both alarms and regular manual checks. When team members spot an out-of-range metric, they participate directly in adjusting storage or escalating for deeper checks.
Over years, compliance for 2',6'-Pipecoloxylidide has evolved. Authorities ask about trace control—metal impurities, solvent residues, even non-standard solvent bands. We stay up to date with changing United States Pharmacopeia and European Pharmacopoeia requirements, but also consult with industry experts about new analytical techniques before regulations fully require them.
Our records for each batch go well past minimums, storing spectral, elemental, and batch process data for many years so any future question from clients finds a direct answer. We see regulatory questions as a chance to tighten our process further. Transparency and full disclosure keep us on the recommended supplier lists not only through good audits but also after proper reporting when field events occur. Every corrective action closes the loop not only on paperwork, but on shop floor learning.
Sustainable production is no short-term buzzword for us. In managing 2',6'-Pipecoloxylidide production, we've engineered waste recovery into upstream and downstream flows. Organic solvent reuse flows into our policy not just for cost savings, but to limit volatile organic compound emissions. Our energy use receives hard monthly review against historical benchmarks, with older equipment retired in favor of more efficient pumps and chillers.
For waste handling, all streams are collected, sampled, then sent to licensed handlers or processed through on-site treatment units. We publish total annual waste, process loss rates, and solvents recovered as a share of input. We've learned through hard experience that overcomplex solvent systems in reaction design only burden both environment and operator, and we regularly revisit process chemistry to simplify where possible.
Process improvement doesn't come from lab reports alone, but from daily engagement with operators and customers. We keep detailed records of past failures, flag "near-miss" events in handling or purity margins, and use those stories in training sessions. New process control computers allow us to spot trends in temperature drift and mixing cycles we could not see before, improving both repeatability and troubleshooting speed.
We fund internal chemistry projects for alternate synthesis routes and solvent optimizations, occasionally partnering directly with university research labs who need real-world trial runs. Some of our best tweaks to production have started from a single observation in an unrelated product or from customer feedback describing an unexpected benefit in use.
Most of our customers come back year after year—and not just for a price quote. They know the value lies in working with a manufacturer who answers the phone in person, shares practical advice, and owns up to issues. Over the years, we have adjusted specification windows, delivery formats, and technical data sheets based on user input gathered at every step. This close loop ties purchasing, production, and end-use teams in a way that goes past the typical supplier relationship.
Shared learning, trust, and a keen sense of daily realities shape everything we do with 2',6'-Pipecoloxylidide. We believe those values—practiced not through slogans but through steady attention to detail—deliver the most value. Each kilogram shipped carries our local experience with it: process improvements from real-world use, technical support from people who have run the same chemistry in their own reactors, and a dedication to both compliance and innovation.